National Preclinical Sepsis Platform: developing a framework for accelerating innovation in Canadian sepsis research.
Mendelson AA, Lansdell C, Fox-Robichaud AE, Liaw P, Arora J, Cailhier JF, Cepinskas G, Charbonney E, Dos Santos C, Dwivedi D, Ellis CG, Fergusson D, Fiest K, Gill SE, Hendrick K, Hunniford VT, Kowalewska PM, Krewulak K, Lehmann C, Macala K, Marshall JC, Mawdsley L, McDonald B, McDonald E, Medeiros SK, Muniz VS, Osuchowski M, Presseau J, Sharma N, Sohrabipour S, Sunohara-Neilson J, Vázquez-Grande G, Veldhuizen RAW, Welsh D, Winston BW, Zarychanski R, Zhang H, Zhou J, Lalu MM; Sepsis Canada’s National Preclinical Sepsis Platform.
Mendelson AA, et al.
Intensive Care Med Exp. 2021 Mar 19;9(1):14. doi: 10.1186/s40635-020-00366-4.
Intensive Care Med Exp. 2021.
PMID: 33738642
Free PMC article.
Despite decades of preclinical research, no experimentally derived therapies for sepsis have been successfully adopted into routine clinical practice. ...To this end, we organized the first meeting of the National Preclinical Sepsis Platform …
Despite decades of preclinical research, no experimentally derived therapies for sepsis have been successfully adopted into ro …